GeneWerk is now ProtaGene, with locations in the United States and Germany.
You will be redirected in 10 seconds.
Driven by patient safety, we enable cell and gene therapy innovators to confidently bring their breakthrough therapies to the clinic.
We support you through the entire clinical journey.
Discover our state-of-the-art assays and technologies platforms.See all Use cases services
Explore how and when you can apply our pioneering technologies.See all Expertise services
GeneWerk is led by renowned experts
in gene therapy safety assessment.
Our project managers Matteo Franco and Marco Zahn are excited to present the “Qualification of an NGS-based assay for the identification and quantification of encapsidated sequences in rAAV batches” (https://api.ltb.io/show/ABGBQ)
the “Standardization and Validation of a Probe-Based qPCR Assay for Lentiviral Vector Copy Number Determination” (https://api.ltb.io/show/ABGAX).
Visit our stacks, enjoy the presentations and get in touch with our team. #ESGCT2021
Read our latest press releases and announcements below.
We mourn the loss of our dear friend, mentor, eminent scientist, co-founder and CEO...
Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand...
GeneWerk will expand capabilities to meet rapidly growing demand for cell and gene therapy...
Genewerk GmbH in collaboration with University Heidelberg Germany provided an insight into spatial and...